Objective: Noninvasive ventilation has been successfully used after thoracic surgery. However, noninvasive ventilation fails in about 20% of patients. The aim of the study was to analyze episodes of noninvasive ventilation failure and to assess possible risk factors, while taking into account the performance of fiberoptic bronchoscopy for secretion management. Methods: From January 2006 to June 2008, the use of noninvasive ventilation was prospectively recorded after thoracic surgery. Data were retrospectively abstracted from charts, including the number of fiberoptic bronchoscopies performed. Risk factors associated with noninvasive ventilation failure were evaluated using logistic regression analysis to estimate odds ratios (ORs) and their 95% confidence intervals (CIs). Results: During the study period, 664 patients were admitted in the intensive care unit (ICU) after lung resection or pulmonary thromboendarterectomy.
Introduction
Patients undergoing lung surgery are thought to be at high risk for the development of postoperative pulmonary complications [1] . Prolonged invasive mechanical ventilation is an important risk factor associated with the occurrence of respiratory complications [1] . Several years ago, our group found that, in selected patients with acute respiratory failure following lung resection, noninvasive ventilation (NIV) was able to decrease the need for invasive mechanical ventilation and to improve clinical outcome [2] . However, about 20% of patients under NIV needed to be subsequently intubated after lung resection [2, 3] . Delays in reintubation after the development of acute respiratory failure actually correlated with worsened survival rates [4, 5] . Therefore, early identification and surveillance to determine which patients require reintubation appears essential. Such patients should be promptly intubated because a delay in reintubation permits the development of a respiratory crisis, requiring emergent intubations, and increasing the likelihood of morbidity and mortality [4, 6] . It is clear that for NIV to be successful, airway secretion management must be addressed [7] . Fiberoptic bronchoscopy (FOB) is a therapeutic option when other methods fail [8, 9] . Thus, the number of FOBs performed could be an important marker of the severity of retained secretions and atelectasis [8] .
The primary objective of the study was to evaluate the incidence of NIV failure and the possible risk factors associated, when taking into account the performance of FOB. The second objective was to assess the outcome of patients with NIV failure in terms of mortality and the occurrence of nosocomial pneumonia.
Patients and methods
Our local ethic committee approved the study. The use of NIV was prospectively recorded from January 2006 to June 2008. The charts of all patients, who had undergone pulmonary resection or pulmonary thromboendarterectomy (PTE) and have benefited from NIV in our institution, were reviewed. Emergency procedures and lung transplantations were excluded from the analysis.
Perioperative management
All pulmonary resections from wedge resection to pneumonectomy were performed by open thoracotomy. All patients were intubated with a double-lumen endotracheal tube. Operability was determined according to existing guidelines for pneumonectomy and lobectomy. However, the attending surgeon made the final decision regarding operability. Unless otherwise indicated, all patients after pulmonary resection were scheduled for extubation in the operating room. PTE was performed according to a standardized technique [10] . All patients were operated upon by a median sternotomy under cardiopulmonary bypass.
Patients received antibiotic prophylaxis with a secondgeneration cephalosporin (cefamandole, 1.5 g at the induction of anesthesia and on the first postoperative day, 750 mg four times). Discussion concerning direct intensive care unit (ICU) admission after resection was established on the basis of type and extent of resection, predicted postoperative lung function, and associated comorbidities. Upon discharge from the recovery room, patients were managed in the thoracic ward unless complications required their admission to the ICU. All patients after PTE were admitted directly to the ICU under mechanical ventilation. Postoperative analgesia was mainly achieved by multimodal pain management: full regular dose of acetaminophen, nefopam, tramadol, and systemic opioids (parenteral administration or i.v. patient-controlled administration). Sometimes nonsteroidal anti-inflammatory drugs and ketamine was also added. Some patients received epidural analgesia.
Nebulized bronchodilators (terbutalin 5 mg and ipratropium bromide 500 mg four times a day) and budesonide (500 mg twice a day) were prescribed at the convenience of the attending physician. All patients had an active program of physiotherapy during the postoperative period. Two respiratory therapists routinely visited the patients twice daily or more frequently, if required, from 7 am to 7 pm. FOB was performed at the discretion of the attending physician and was available 24 h a day.
Noninvasive ventilation
NIV was provided via a PerformaTrak Mask (PerformaTrack TM ; Respironics Inc., Murrysville, PA, USA). The mask covers the nose and mouth and exists in three sizes: small, medium, and large. NIV was provided with the Bi-PAP S/T-D Ventilatory Support System (Bipap Vision; Respironics Inc., Murrysville, PA, USA). Pressure support was increased, starting from 8 cm H 2 O, to achieve an exhaled tidal volume of 8-10 ml kg À1 and a respiratory rate of less than 25 breaths min À1 . Positive end-expiratory pressure was initially set at 4 cm H 2 O. NIV was performed for an intermittent period of approximately 1 h every 4 h or more, if needed, until clinical respiratory stability was achieved.
Criteria for reintubation
Such criteria had been previously reported by our team [2] and were still use at the time of the study [2] . Reintubation was performed if at least one major criterion or two minor criteria were present. Major criteria included respiratory arrest, respiratory pauses with loss of consciousness or gasping respiration, encephalopathy, and cardiovascular instability. Minor criteria included a 20% or more increase in respiratory rate or in arterial carbon dioxide tension (PaCO 2 ), or a greater than 20% fall in PaO 2 compared with baseline.
Copious secretions that could not be adequately cleared or that were associated with acidosis, hypoxemia, or change in mental status were also added. The final decision to reintubate was made by the treating physician.
Charts' evaluation
Charts were evaluated according to the method of Feinstein et al. [11] . The following data were abstracted by means of a standardized form: age, sex, body mass index (BMI), comorbid cardiovascular conditions (preexisting history of myocardial infarction, angina pectoris, and hypertension), diabetes, preoperative pulmonary function tests, American Society of Anesthesiologists (ASA) class, type and duration of pulmonary resection, perioperative transfusion, epidural analgesia, NIV management, number of FOBs performed during NIV appliance, and presence of invasive ventilation at ICU admission. Obesity was defined as a BMI > 30 kg m À2 . The severity of illness was evaluated with the first-day Simplified Acute Physiology Score (SAPS II), and the Sequential Organ Failure Assessment (SOFA) score.
During the first 48 h of NIV, the following data were abstracted: duration of NIV: number of FOBs performed, arterial blood gas analysis, and course of SOFA score and radiologic score [12] . Radiologic lesions were documented on a chest radiography and scored as follows: the right and the left pulmonary areas were divided in three zones, and each zone was scored from 0 (no radiologic lesion) to 2 (dense radiologic lesion). Then, scores of the six zones were summed (minimum, 0; maximum, 12).
Postoperative complications were ascertained by detailed review of both medical and nurse charts according to the definitions reported below.
Definitions of postoperative complications
(1) Nosocomial-acquired pneumonia: In patients under mechanical ventilation, the diagnosis of nosocomial pneumonia was considered when they developed a new and persistent lung infiltrate and had purulent tracheal secretions, confirmed by a bacterial culture of the sputum ! 106 colony forming units (CFU) ml À1 or of the bronchoalveolar lavage ! 104 CFU ml À1 obtained during FOB. In patients breathing spontaneously, the diagnosis was considered if they had a compatible chest radiograph and purulent sputum with Gram stain and sputum culture documenting the presence of microorganisms. 
Statistical analysis
Data were computerized and analyzed using Statview 5.0 statistical packages (SAS Institute Inc., SAS campus drive, Cary, NC, USA). Based on our previous experience and the data previously reported, we hypothetized an incidence of NIV failure of approximately 25%. Therefore, for an incidence with a precision of 8%, 120 patients under NIV must be included. Normality of the distribution of data was assessed by the Kolmogorov-Smirnov test. Normally distributed continuous variables were compared using the Student's ttest and expressed as the mean AE SD. Non-normally distributed continuous variables were compared using the Mann-Whitney U-test and expressed as the median (25th-75th percentiles]. Chi-square tests or Fisher's exact test were used to compare proportions and rates. A p value < 0.05 was considered significant. Changes in arterial blood gas, vitals signs, SOFA and radiologic scores, and NIV duration during the first 48 h of NIV were analyzed using repeated measures analysis of variance (ANOVA) followed by the Scheffé F-test, as appropriate. The risk of NIV failure associated with selected factors was evaluated using logistic regression analysis to estimate odds ratios (ORs) and their 95% confidence intervals (CIs). A p value 0.05 for variables univariately associated with NIV failure during the first 48 h of NIV was chosen as the criterion for submitting variables to the model. Goodness of fit was assessed by the Hosmer and Lemeshow chi-square test. R 2 was used to measure the model performance.
Results

Study population
From January 2006 to June 2008, 664 patients were admitted to the ICU after thoracic surgery. A total of 135 patients underwent NIV (20.3% (95% CI: 18.7-21.9)) (Fig. 1) . As many as 40 of these 135 patients needed to be intubated (29.6% (95% CI: 21.9-37.3)) and represented the NIV failure group.
There were no missing data except for blood gas analysis. A total of 106 patients were admitted to the ICU the day of surgery, while 29 after a median of 1 day (1-2.5). Baseline characteristics at the time of admission to the ICU for patients with NIV failure or success are reported in Table 1 .
Major differences are related to the higher number of PTE procedures in the NIV success group and to the high number of patients admitted to the ICU under invasive mechanical ventilation in the NIV failure group.
Management of NIV
NIV was applied at a median of 3 days after the surgical procedure. Table 2 shows characteristics of patients at NIV initiation. In the NIV failure group, patients were more hypoxemic and hypercapnic at the time of NIV initiation.
NIV was applied during a similar number of days in the success and failure NIV groups (3.0 days (2.0-5.0) vs 3.0 days (2.0-5.5), p = 0.93). The median number of intermittent period of NIV performance was also similar: 9 (6-16) versus 10 (6-18); p = 0.63 in the success and failure NIV groups, respectively. However, the total number of hours spent on NIV was significantly different between patients with success 
Response to NIV during the first 48 h and risk factors of NIV failure
The changes in hemodynamics, blood gas values, and respiratory rates during the first 48 h are shown in Table 3 . The respiratory rate was significantly lower in the NIV success group as soon as the 2nd-4th h after the beginning of NIV. As early as the 2nd-4th h, the number of hypoxemic patients (SaO 2 < 92%) decreased in both groups ( p < 0.0001). Course of pH, PaCO 2 , and PaO 2 /FiO 2 ratio were not statistically different between the two groups.
Median time spent under NIV became significantly different after the 24th h and 60% of patients in the failure group underwent at least one FOB during the second day of NIV. Patients in the failure group had significantly a higher SOFA score as early as the 24th h. Radiologic score decreased significantly with NIV only in patients who were successfully treated with NIV after 48 h ( p = 0.03).
A logistic regression model was built taking into account variables univariately associated with NIV failure during the first 48 h of NIV (Table 3) . Risk factors are reported in Table 4 . The goodness of fit chi-square of this model remained nonsignificant ( p = 0.36). This model explained 17% of the variance in the data (R 2 = 0.17). Timing and reasons for endotracheal intubation are shown in Fig. 2. 
Outcome
Outcome variables and complications in the success or failure groups are shown in Table 5 . Nosocomial pneumonia was the leading cause of respiratory complications and occurred 3.0 days (3.0-4.0) and 5.0 days (2.7-7.0) after the institution of NIV in the success and failure groups, respectively ( p = 0.13). In the 21 cases occurring in the NIV failure group, microbiological etiology was documented: nine Enterobacteriaceae sp, seven Pseudomonas aeruginosa, six methicillin-sensible Staphylococcus aureus, and four other species. Five cases of nosocomial pneumonia were polymicrobial. In the success NIV group, no P. aeruginosa was isolated.
In the NIV failure group, patients underwent invasive mechanical ventilation during a median of 4.0 (1.5-12.5) days and 17 patients (42.5%) underwent tracheotomy at a median of 11.0 (9.7-17.0) days after ICU admission. Patients in the failure group had a longer duration of ICU and hospital stay, and a higher mortality rate. Of the eight patients who died, four were under NIV 3 days and four patients ! 4 days.
Discussion
We reported a rate of 30% of NIV failure after thoracic surgery, when airway secretion management was taken into account. Respiratory rate, hours spent under NIV, number of FOBs performed, and development of organ failure were the risk factors of NIV failure identified. The mortality rate following NIV failure was 20%.
Our study is probably limited by several concerns. First, it is acknowledged that retrospective identification of complications depends on the detail and completeness of the medical record. To minimize this factor, the analysis was limited to postoperative complications thought to be clinically significant, and thus unlikely to be omitted from the medical record. Second, we have included patients with pulmonary resection and patients with PTE. Both lateral thoracotomy and sternotomy induced increases in pulmonary and respiratory system tissue resistances, and also lung elastance [14] . Lung parenchyma is also involved during PTE [10] . Although the main complication after PTE was reperfusion lung edema [10] , incidence of pneumonia was similar in PTE and lung resection patients (around 22%) as previously reported [1, 3, 10] . Third, performance of FOB was not standardized. However, physicians in our team agreed to the large majority of FOB indications. Fourth, one cannot show causality from a retrospective study, only association that may be causal. Lastly, the study was performed at a single medical center and deserves further confirmation in other institutions.
Compared with 1997, the 2002 French survey showed a significant increase in NIV use in ICUs from 16% to 24% [15] . After lung resection, 12.9% of operated patients received [ ( F i g . _ 2 ) T D $ F I G ] NIV, in a recent study [3] . However, NIV was ineffective in some patients and concerns have been raised, related to a higher mortality rate reported in such patients [4, 5] . Since the first randomized study published by our group in 2001 [2] , few studies have reported the effect of NIV following thoracic surgery [16] . The failure rate of NIV ranged from 19% to 72% (2) (3) (4) (17) (18) (19) (20) . Population heterogeneity and causes of acute respiratory failure are probably the two major factors implied to explain such a discrepancy. Thus, in lung resection patients, NIV failure occurred in 40% of cases and nearly 10% in PTE patients. We reported a failure rate of 30%, which is 10% higher of our previous report [2] , but the severity of illness has also increased (SAPS II from 17 to 24 points). In the same population, a recent study reported a NIV failure rate of 19% in hypoxemic patients [3] .
Modalities of NIV application could be of interest for the success or failure rate. The mean daily duration of NIV during the first 48 h and the duration of NIV was comparable in a similar study [3] . Moreover, the mean tidal volume obtained was around 8 ml kg À1 as reported by most authors [4, 17, 20] . Secretion management must also be considered when reporting success or failure of NIV [7] . To our knowledge, no previous studies have dealt with this important parameter. Failing to maintain clear airway results in increased airway resistance to NIVand patient fatigue [7] , and is associated with atelectasis and pneumonia [13] . Thus, about 40% of our patients had sputum retention before initiation of NIV, when previous studies reported a rate between 8% and 30% [3, 13] . Of note, sputum retention was mainly a complication of lung resection rather than PTE. Such discrepancies could be related to the lack of objective definition. Bronchoscopy is aimed at clearing mucous secretions and plugs, especially when other methods fail [8] . Our results showed that only 20% of patients needed a FOB during the first 24 h, but 50% of patients in the failure group needed a FOB after 48 h of NIV. Thus, FOB was identified as an independent risk factor. Therapeutic FOB for retained secretions and atelectasis has a wide range of success rate (19-89%) [8, 9] . Moreover, FOB in critically ill patients is not without risk, including hypoxemia, hemodynamic instability, and complications related to sedation when used [9] .
It is important to identify patients, who are less likely to improve with NIV. This is particularly true for the most severely ill patients when unnecessary delays in intubation may have serious consequences. Lefevre et al. have shown that previous cardiac comorbidities and no initial response to NIV were risk factors of NIV failure after lung resection [3] . In addition to FOB performance, we have identified three early risk factors: severity of illness; respiratory rate, and number of hours spent on NIV. Severity of illness has been identified in numerous studies [15, [18] [19] [20] and development of organ failure should be taken into account to decide or not to maintain NIV. Respiratory rate is recognized as a measure of therapeutic effect [21] and has been also identified in other studies [19, 20] . Finally, number of hours spent on NIV depends on the speed of resolution of the respiratory failure [21] . The point at which NIV should be abandoned and the patient intubated will vary with each individual and cause of respiratory failure [18, 22] . Interestingly, alteration of preoperative pulmonary function test was not predictive of NIV failure [3] as it was already the case for postoperative pulmonary complications [1] .
Pneumonia developed in 53% of subsequent intubated patients, while only six episodes of pneumonia were detected in the 95 patients, who avoided intubation. Many authors have underscored the inherent advantage of NIV in decreasing the risk for developing lower respiratory tract infections [5, 17, 18, 23] . The incidence of pneumonia has a large variability from 2% to 40% [24] . However, in two recent prospective studies, the incidence ranged between 12% and 25% [3, 24] . Pneumonia is the leading cause of acute respiratory failure after lung surgery [1, 3, 24] and it is associated with a high mortality rate [1, 3, 24] . The failure of NIV could potentially represent a risk factor for infectious complications [21, 25] . Some large studies led to conflicting results. Antonelli et al. reported in two different clinical settings that NIV failure was associated with a higher risk of pneumonia [18, 19] . However, a recent prospective survey did not corroborate the former results [5] . Several studies have shown that NIV failure was associated with higher ICU mortality [4, 5, [17] [18] [19] . This could be related to a delay in reintubation [4] , which could promote unexpected cardiac or respiratory arrest, aspiration pneumonia, and complication of emergent intubation. However, in our study, NIV failure is probably a marker for more severe disease as SOFA score also increases and timing of reintubation does not influence the mortality rate.
In conclusion, our study suggests that NIV failure is mainly related to the progression of acute illness. Performance of FOB seems to influence the prognosis of NIV and nosocomial pneumonia remains the leading cause of respiratory complications after lung surgery. Although NIV has an established role as initial therapy of respiratory failure after lung surgery, it should not be continued for patients, who failed to improve rapidly or need successive FOB.
